Search Count: 40
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2022-11-30 Classification: RNA Ligands: TEP, MG, NA |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2022-11-30 Classification: RNA/IMMUNE SYSTEM Ligands: K, NA |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2022-11-30 Classification: RNA Ligands: QB3, NA, MG |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2022-11-30 Classification: RNA Ligands: QAX, MG, NA |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.64 Å Release Date: 2022-11-30 Classification: RNA Ligands: QIJ, MG, CA, NA |
 |
Organism: Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2022-11-30 Classification: RNA Ligands: QEU |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2022-11-30 Classification: RNA/IMMUNE SYSTEM |
 |
Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With A Pyrrolo[2,3-D]Pyrimidine Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.51 Å Release Date: 2022-01-19 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: CL, 7QU |
 |
Organism: Leishmania donovani
Method: ELECTRON MICROSCOPY Release Date: 2020-08-26 Classification: HYDROLASE Ligands: N2E |
 |
Leishmania Tarentolae Proteasome 20S Subunit Complexed With Lxe408 And Bortezomib
Organism: Leishmania donovani
Method: ELECTRON MICROSCOPY Release Date: 2020-08-26 Classification: HYDROLASE Ligands: BO2, N2E |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.70 Å Release Date: 2020-03-04 Classification: TRANSFERASE Ligands: Q8J |
 |
Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With A Pyrazolo[1,5-A]Pyrimidine Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2020-02-26 Classification: Transferase/Transferase Inhibitor Ligands: QX1, SO4, CL, ACT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2018-02-14 Classification: IMMUNE SYSTEM Ligands: EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2018-02-14 Classification: IMMUNE SYSTEM Ligands: EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-02-14 Classification: IMMUNE SYSTEM Ligands: EDO, BTN |
 |
Identification Of Potent And Selective Ripk2 Inhibitors For The Treatment Of Inflammatory Diseases
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2017-10-25 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 9WS, SO4 |
 |
Identification Of Potent And Selective Ripk2 Inhibitors For The Treatment Of Inflammatory Diseases.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.89 Å Release Date: 2017-10-25 Classification: Transferase/Transferase Inhibitor Ligands: 9XA |
 |
Egfr Kinase Domain In Complex With A Covalent Aminobenzimidazole Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2016-07-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5X4 |
 |
Egfr Kinase Domain T790M Mutant In Complex With A Covalent Aminobenzimidazole Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2016-07-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5X4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.40 Å Release Date: 2016-07-27 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 5XH |